Liang Sang

Dr. Liang Sang

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2025 in Advanced Science
Verified
Journal Article
Open access
ZCZhiguang Chen
Zhiguang Chen
LSLiang Sang
Liang Sang
YLYanjun Liu
Yanjun Liu
ZBZhiQun Bai
ZhiQun Bai
Sonodynamic therapy (SDT) represents a promising approach for cancer treatment. Compared to photodynamic therapy, SDT offers increased penetration depth and higher precision. However, the practical application of SDT is constrained by the low water solubility, poor tumor specificity, and metabolic susceptibility of most sonosensitizers. Recent research has explored the use of piezoelectric materials as sonosensitizers in cancer treatment and inhibition of bacterial growth. Upon ultrasound excitation, the separation of electron–hole (e−–h+) pairs occurs within the piezoelectric material. By improving the crystal structure of the material or incorporating other nanoparticles to prevent rapid recombination of e−–h+ pairs, the piezoelectric material accumulates charges in the conduction band and valence band, achieving the redox potential of O2/·O2−. This enables the piezoelectric material to serve as a sonosensitizer, leading to the concept termed Sono‐Piezo Dynamic Therapy (SPDT). This review aims to define the concept of SPDT, provide a systematic overview of the historical development of piezoelectric materials in the application of SDT, and elucidate the potential mechanisms by which piezoelectric materials act as sonosensitizers. Importantly, various piezoelectric materials will be discussed in terms of their feasibility, advantages, and disadvantages as sonosensitizers, offering new perspectives for identifying potential sonosensitizers.

30 March 2026 in Theranostics
Verified
Journal Article
Open access
PDF file
SLSinong Li
Sinong Li
ZYZiyi Yang
Ziyi Yang
YZYing Zhang
Ying Zhang
GZGenyuan Zhang
Genyuan Zhang
ZCZoujuan Cai
Zoujuan Cai
LSLiang Sang
Liang Sang
Sonodynamic therapy (SDT), a tumor treatment modality characterized by deep tissue penetration and high spatiotemporal precision, faces multiple challenges in clinical translation, including suboptimal sonosensitizer efficiency, suppression by the tumor microenvironment (TME), and insufficient induction of antitumor immune responses. This paper systematically reviews the multifaceted sensitization strategies of SDT, breaking away from traditional single-optimization approaches to establish a comprehensive synergistic enhancement framework spanning the entire chain involving “material design-microenvironment regulation-immune remodeling-synergistic therapy.” In sonosensitizer engineering, current research emphasizes advanced design strategies—including defect engineering, heterostructure construction, and piezoelectric materials—to markedly enhance reactive oxygen species (ROS) generation through band structure modulation and mechano-electro-chemical coupling effects. To overcome the TME-associated constraints, a series of innovative strategies such as hypoxia alleviation, antioxidant depletion, metabolic reprogramming and bacteria-mediated targeted delivery have been developed to mitigate ROS scavenging and improve tumor selectivity. Furthermore, this review summarizes how SDT is integrated with multiple synergistic modalities such as chemodynamic therapy, phototherapy, immunotherapy, and ferroptosis/cuproptosis induction and systematically elucidates the underlying mechanisms and therapeutic potential of these combinations in triggering immunogenic cell death, reversing tumor immunosuppression, and ultimately enabling diagnostic-therapeutic integration. Despite persistent challenges in nanodelivery, controllable ROS generation, and clinical standardization, this review highlights that the development of multimodal, responsive, and biohybrid platforms is driving SDT toward a new paradigm of precise and intelligent cancer treatment. Collectively, these findings provide a systematic strategic blueprint with translational potential for treating deep-seated and drug-resistant solid tumors.

7 June 2024 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
SLSinong Li
Sinong Li
ZDZheng Ding
Zheng Ding
XLXiang Li
Xiang Li
MFMiao Fu
Miao Fu
LSLi Sang
Li Sang
LSLiang Sang
Liang Sang
Objective: This meta-analysis examines peak systolic velocities (PSVs) in thyroid arteries as potential biomarkers for thyroid disorders, which includes treated and untreated Graves’ disease(GD) and destructive thyrotoxicosis(DT).Methods: A search across databases including PubMed, Google Scholar, Embase, and Web of Science identified studies assessing peak systolic flow velocity in the inferior thyroid artery (ITA-PSV) and superior thyroid artery (STA-PSV) diagnostic efficacy in GD and DT.And the search was restricted to publications in the English language.The analysis compared STA-PSV and ITA-PSV across patient groups, evaluating intra-group variances and synthesizing sensitivity and specificity data.Results: The analysis covered 18 studies with 1276 GD, 564 DT patients, and 544 controls. The difference of STA-PSV between GD group, DT group and normal group and the difference of ITA-PSV were analyzed in subgroups, and there was no statistical significance between subgroups when comparing any two groups. Normal subjects displayed intra-group ITA-PSV and STA-PSV differences with established cut-off values of 20.33 cm/s (95% CI, 17.48-23.18) for ITA-PSV and 25.61 cm/s (95% CI, 20.37-30.85) for STA-PSV. However, no significant intra-group differences were observed in the STA-PSV and ITA-PSV cut-off values among groups with GD or DT. The combined cut-off values for these patient groups and normal subjects were 68.63 cm/s (95% CI, 59.12-78.13), 32.08 cm/s (95% CI, 25.90-38.27), and 23.18 cm/s (95% CI, 20.09-26.28), respectively. The diagnostic odds ratio(DOR) for these values was 35.86 (95% CI, 18.21-70.60), and the area under the summary receiver operating characteristic (SROC) curve was 0.91, with a sensitivity estimate of 0.842 (95% CI, 0.772-0.866).Conclusion: PSVs in thyroid arteries are useful diagnostic tools in distinguishing DT from GD. A PSV above 68.63 cm/s significantly improves GD diagnosis with up to 91% efficacy. No notable differences were found between superior and inferior thyroid arteries in these conditions.

1 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MZMinghui Zhang
Minghui Zhang
SZShuangqingyue Zhang
Shuangqingyue Zhang
YWYan Wang
Yan Wang
ZYZijun Yu
Zijun Yu
ZYZiyi Yang
Ziyi Yang
LSLiang Sang
Liang Sang
This study aims to examine the determinants of contralateral central lymph node metastasis in cases of unilateral papillary thyroid carcinoma, utilizing clinical pathological parameters and ultrasound radiomics. The goal is to develop an optimal predictive model that can inform clinical decisions regarding contralateral central lymph node dissection in patients with unilateral papillary thyroid cancer. A cohort of 329 patients diagnosed with unilateral papillary thyroid carcinoma, all of whom underwent bilateral thyroidectomy and bilateral central lymph node resection, were analyzed. Clinical data were systematically collected, and a logistic regression analysis model was constructed. The patient cohort was randomly divided into a training set and a validation set in an 8:2 ratio. Radiomic features were extracted from ultrasound images using the open-source software pyradiomic, leading to the establishment of three models: a clinical model, a radiomics model, and a combined clinical and radiomics model. The area under the curve (AUC) for the logistic regression model was found to be 0.843. In the training set, the AUCs for the clinical model, the radiomics feature model, and the combined clinical and radiomics feature model developed using random forest were 0.7645, 0.9633, and 0.9726, respectively. In the validation set, the AUCs for the clinical model, the radiomics feature model, and the combined clinical and radiomics feature model developed using random forest were 0.7358, 0.9558, and 0.9694, respectively. The combined model incorporated four clinical features and seven radiomic features, specifically: age, tumor size, presence of microcalcification, presence of ipsilateral central lymph node metastasis, elongation, perimeter, sphericity, maximum probability, large dependence emphasis, first-order range, and cluster shade. The combined clinical and radiomics model developed in this research demonstrates strong predictive diagnostic efficacy. The establishment of this innovative model is anticipated to provide a robust theoretical framework for clinicians considering preventive bilateral central lymph node dissection in patients with unilateral papillary thyroid carcinoma.

15 June 2025 in World Journal of Gastrointestinal Oncology
Verified
Journal Article
Open access
ZYZi-Yi Yang
Zi-Yi Yang
WWWei-Na Wan
Wei-Na Wan
LZLei Zhao
Lei Zhao
SLSi-Nong Li
Si-Nong Li
ZLZhe Liu
Zhe Liu
LSLiang Sang
Liang Sang
BACKGROUND The expression level of Ki-67 and the degree of differentiation in pancreatic cancer determine tumor aggressiveness and patient prognosis, which holds significant implications for clinical decision-making. A major challenge in preoperative pancreatic ductal adenocarcinoma management is predicting tumor malignancy. Contrast-enhanced ultrasound (CEUS), a dynamic imaging technique based on blood pool visualization, can reveal lesion vasculature and provide quantitative perfusion data reflecting angiogenesis. By tracking contrast agent kinetics, CEUS offers non-invasive insights into tumor vascularization, helping assess malignancy potential. AIM To investigate the correlation between Ki-67 and pancreatic cancer differentiation using CEUS quantitative parameters and evaluated their diagnostic accuracy. METHODS This retrospective study analyzed pancreatic cancer patients who underwent CEUS and pathological confirmation. Pathological differentiation, clinical data, and quantitative CEUS parameters [maximum intensity (IMAX), rise time (RT), rise slope 50% (Rs50), rise slope 10%-90% (Rs1090), etc. ] were collected. Based on Ki-67 expression (< 50% vs ≥ 50%), patients were divided into low- and high-expression groups. The study evaluated correlations between Ki-67 expression, differentiation degree, and CEUS quantitative parameters to assess tumor aggressiveness. RESULTS Among 54 patients (25 high Ki-67, 29 low Ki-67), significant differences (P < 0.05) were observed in Rs50, IMAX, wash-out area under the curve (WoutAUC), wash-in and out area under curve, and Rs1090 between high and low Ki-67 groups. High-expression patients showed elevated Rs50, IMAX, WoutAUC, and area under the curve (AUC), while RT and falling slope 50% (Fs50) were lower. Rs1090 demonstrated the highest diagnostic accuracy (AUC = 0.863, sensitivity = 0.92, specificity = 0.759). Fs50 was effective in low Ki-67 detection (AUC = 0.838). No correlation was found between enhancement patterns and Ki-67 or differentiation. CONCLUSION CEUS parameters (Rs50, IMAX, WoutAUC, Rs1090) strongly correlate with Ki-67, aiding non-invasive pancreatic cancer assessment. Rs1090/IMAX predict high Ki-67; Fs50 identifies low Ki-67, supporting CEUS for tumor aggressiveness evaluation.

1 August 2024 in Quantitative Imaging in Medicine and Surgery
Verified
Journal Article
Open access
PDF file
ZYZiyi Yang
Ziyi Yang
MLMutian Lv
Mutian Lv
ZYZijun Yu
Zijun Yu
LSLi Sang
Li Sang
MYMingxia Yang
Mingxia Yang
LSLiang Sang
Liang Sang
Background: Contrast-enhanced ultrasound (CEUS) technology has been developed for decades, and its application is becoming increasingly more extensive. In this study, bibliometrics was used to characterize the development status of CEUS over the past 20 years and to identify future research hotspots. Methods: We collected data from the Web of Science and analyzed the literature related to CEUS published from 2002 to 2022. We examined 6,382 publications and analyzed the publication year, country of origin, affiliated institutions, authors, journal, categories, keywords, and research frontiers within the relevant literature. Using bibliometric analysis, we aimed to determine the general research direction and current publication trends. This allowed us to identify the most prolific and outstanding authors, institutions, countries, and keywords in CEUS research. For data collection, analysis, and visualization, we employed VOSviewer (Leiden University, Leiden, the Netherlands), Excel (Microsoft Corp., Redmond, WA, USA), CiteSpace, and biblioshiny. These tools helped us gather, analyze, and visualize the data effectively. Results: The analyzed publications indicated a consistent upward trend in the number of works published between 2002 and 2022. Notably, China and Sun Yat-sen University emerged as the most prolific countries and institutions, respectively. China published 391 articles with 5,817 citations and was the leader in terms of international cooperation. Moreover, pediatrics-related keywords have surged in frequency in recent years. Conclusions: The amount of research on CEUS has increased rapidly and continues to grow, with China being at the forefront of this research field. The application of CEUS in some pediatric diseases is a recent research hotspot and perhaps warrants close attention.